LumiraDx Limited Common Shares
LMDX
LMDX was delisted on the 8th of January, 2024.
25 hedge funds and large institutions have $65.2M invested in LumiraDx Limited Common Shares in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gates Foundation
Seattle,
Washington
|
+$45.2M |
| 2 |
SM
Senvest Management
New York
|
+$7.42M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.44M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$2.06M |
| 5 |
MCM
Moore Capital Management
New York
|
+$1.01M |
Top Sellers
LMDX Hedge Fund Activity: Q3 2021 in Review
25 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Common Shares (LMDX) for Q3 2021, worth a combined $65.2M.
Buyers outnumbered sellers: 25 funds opened new LMDX positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Gates Foundation, opening a new position worth an estimated $45.2M.
- 25 institutional investors held LumiraDx Limited Common Shares (LMDX) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $65.2M of LumiraDx Limited Common Shares stock for Q3 2021.
- 25 funds opened new LumiraDx Limited Common Shares positions in Q3 2021 and 0 closed out, a net change of +25 holders.
- The largest LumiraDx Limited Common Shares buyer in Q3 2021 was Gates Foundation, an estimated $45.2M added.
Based on aggregated 13F filings for Q3 2021.